40401-39-6,
1-(4-Chlorophenyl)-3-methyl-1H-pyrazol-5-amine,
5-Amino-3-methyl-1-(4-chlorophenyl)pyrazole,
1-(4-Chlorophenyl)-3-methyl-1H-pyrazol-5-ylamine,
1H-Pyrazol-5-amine, 1-(4-chlorophenyl)-3-methyl-,
MFCD03478180,
5-Amino-1-(4-chlorophenyl)-3-methyl-1H-pyrazole,
2-(4-Chlorophenyl)-5-methyl-2H-pyrazol-3-ylamine,
EINECS 254-907-3,
ACMC-20apb0,
AC1Q3RAA,
AC1L55CR,
AC1Q2PM0,
MLS001018342,
SCHEMBL1143474,
CHEMBL1313414,
DTXSID6068228,
CTK1D8186,
CLORQKXFDBKDCZ-UHFFFAOYSA-N,
HMS1763B01,
HMS2659E24,
ZINC1081553,
5435AB,
SBB003472,
STL483745,
AKOS000117751,
MCULE-5942896020,
KS-00001Y14,
NCGC00246035-01,
AC-27554,
AJ-24991,
SMR000354626,
TC-172467,
2-(4-chlorophenyl)-5-methylpyrazol-3-amine,
EN300-09621,
1-(4-chlorophenyl)-3-methylpyrazole-5-ylamine,
5W-0357,
I05-2907,
Z55148822,
chondroitin sulfate E (GalNAc4,6diS-GlcA) proteoglycan,
chondroitin sulfate E (GalNAc4,6diS-GlcA), precursor 3,
Chondroitin sulphate e (galnac4,6Dis-glca) proteoglycan,
Chondroitin sulphate e (galnac4,6Dis-glca), precursor 3,
1-(4-Chlorophenyl)-3-methyl-1H-pyrazol-5-ylamine, 97%,
Chondroitin sulfuric acid e (galnac4,6Dis-glca) proteoglycan,
Chondroitin sulfuric acid e (galnac4,6Dis-glca), precursor 3,
Chondroitin sulphuric acid e (galnac4,6Dis-glca) proteoglycan,
Chondroitin sulphuric acid e (galnac4,6Dis-glca), precursor 3,
C10H10ClN3,
C10-H10-Cl-N3,
AR-1G7142,
CID170301,
ZINC01081553,
5336-23-2,